M
Martin Bitzan
Researcher at Montreal Children's Hospital
Publications - 71
Citations - 3384
Martin Bitzan is an academic researcher from Montreal Children's Hospital. The author has contributed to research in topics: Escherichia coli & Focal segmental glomerulosclerosis. The author has an hindex of 28, co-authored 65 publications receiving 3048 citations. Previous affiliations of Martin Bitzan include University of Toronto & McGill University Health Centre.
Papers
More filters
Journal ArticleDOI
An international consensus approach to the management of atypical hemolytic uremic syndrome in children.
Chantal Loirat,Fadi Fakhouri,Gema Ariceta,Nesrin Besbas,Martin Bitzan,Anna Bjerre,Rosanna Coppo,Francesco Emma,Sally Johnson,Diana Karpman,Daniel Landau,Craig B. Langman,Anne Laure Lapeyraque,Christoph Licht,Carla M. Nester,Carmine Pecoraro,Magdalena Riedl,Nicole C. A. J. van de Kar,Johan Vande Walle,Marina Vivarelli,Véronique Frémeaux-Bacchi +20 more
TL;DR: The need for prospective studies to establish evidence-based criteria for the continuation or cessation of anticomplement therapy in patients with and without identified complement mutations is discussed.
Journal ArticleDOI
Epidemiology and diagnosis of Shiga toxin-producing Escherichia coli infections.
TL;DR: There is an urgent need for effective preventive measures based on a detailed understanding of the epidemiology of ST EC infections, and a survey of laboratory methods currently available for diagnosis of STEC is presented.
Journal ArticleDOI
Non-enteropathic hemolytic uremic syndrome: causes and short-term course.
Alex R. Constantinescu,Martin Bitzan,Lynne S. Weiss,Erica Christen,Bernard S. Kaplan,Avital Cnaan,Howard Trachtman +6 more
TL;DR: Although S pneumoniae-related HUS is associated with a less favorable short-term course than other types of non-enteropathic HUS or D+ HUS, the long-term prognosis for recovery of renal function appears to be good in these patients.
Journal ArticleDOI
Molecular detection of sorbitol-fermenting Escherichia coli O157 in patients with hemolytic-uremic syndrome.
TL;DR: Serological tests and DNA analysis performed by restriction endonuclease digestion of B-subunit toxin genes revealed that all 17 isolates produced Shiga-like toxin II, and a high frequency of sorbitol-fermenting E. coli O157 strains was established in the patients examined.
ORIGINAL INVESTIGATIONS Pathogenesis and Treatment of Kidney Disease and Hypertension Non-Enteropathic Hemolytic Uremic Syndrome: Causes and Short-Term Course
Alex R. Constantinescu,Martin Bitzan,Lynne S. Weiss,Erica Christen,Bernard S. Kaplan,Avital Cnaan,Howard Trachtman +6 more
TL;DR: In this article, the authors describe the current incidence, causes, demographic features, hospital courses, and short-term outcomes of non-enteropathic HUS and compare them with those obtained from a contemporaneous cohort of children withenteropathic or diarrhea-associated HUS (D HUS) diagnosed and treated at the same clinical sites.